090 - Curis Shows Positive Data in AML with First in Class IRAK4 Inhibitor

Поділитися
Вставка
  • Опубліковано 15 гру 2024

КОМЕНТАРІ • 7

  • @theDIOyears
    @theDIOyears 3 роки тому +2

    I really appreciate the hard work you put into these videos. Not only are these videos put together in an easy and consice manner to understand, they go into great detail into the various pathways drugs can target in patient cells.
    Throwback to my days in university. Love your presentation!
    Please keep it up!!

  • @Anonymous-fp1xg
    @Anonymous-fp1xg 3 роки тому +1

    Matthew- How can you do such a detailed video.. I'm surprised to see such an effort from your end consistently.. Do you do this just for UA-cam or for other needs? Either way you are man of detail. Thanks much.. Appreciate all your effort.

    • @breakingbiotech
      @breakingbiotech  3 роки тому +2

      Thank you! The details matter when considering an investment. Even at this detail there's unknowns about the future. I do this because it pushes me understand the company or sector to a greater degree than if I just browsed the corporate presentation.

    • @ciresica86
      @ciresica86 3 роки тому

      @@breakingbiotech Hi Matt! On the same note.. great content. I also wondered, what is your goal? Is it to reach a broader audience, or keep it specialized while building a personal brand (detail orientation, dilligence, big brain etc)
      Would you consider doing Breaking Biotech Short Clips? With your knowlwdge, there is great potential in reaching bigger audience.

  • @bekincai
    @bekincai 3 роки тому

    awesome presentation. any ideas why it sold off today June 11? data was the same?

    • @breakingbiotech
      @breakingbiotech  3 роки тому

      Check my latest episode where I discuss it in more detail!